NCT06779552Recruiting
CardioMEMS HF System Coverage With Evidence Development Study
Source: ClinicalTrials.gov · Last updated 3 Apr 2026
Brief summary (registry, in English)
The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 13 Jan 2025
- Start date
- 7 Feb 2025
- Primary completion date
- 31 Mar 2032
- Lead sponsor
- Abbott Medical Devices
- Diseases
- Heart failure
- NCT number
- NCT06779552
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 7 Feb 2025 to the primary completion date, 31 Mar 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subject received prior PA pressure sensor implant (control arm only)
Other illness
- Subject has history of heart transplant or durable mechanical circulatory device
Other
- Subject hospitalized with cardiogenic shock or sepsis
Who the study is looking for
- Subject implanted with a CardioMEMS pressure sensor (treatment arm only)
- Subject \>=18 years of age at time of implant
- Subject has a history of acute decompensated HF or HF-related congestion defined by at least one of the following qualifying event types: HF hospitalization, elevated BNP/NT-proBNP
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Abbott Coordinator of this site? Confirm its status | Pleasanton | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.